Anaesthesia pharmacoeconomics

  • David R. Bevan

La pharmaco-économie et l’anesthésie


  1. 1.
    Cooper CG, Maxwell V. Anaesthetic drug costs are not increased by propofol (Corresp). Can J Anaesth 1992; 39: 1000.PubMedCrossRefGoogle Scholar
  2. 2.
    Doze VA, Westphal LM, White PF. Comparison of propofol with methohexital for outpatient anesthesia. Anesth Analg 1986; 65: 1189–95.PubMedCrossRefGoogle Scholar
  3. 3.
    Bootman JL, Larson LN, McGhan WF, Townsend RJ. Pharmacoeconomic research and clinical trials: concepts and issues. Ann Pharmacother 1989; 23: 693–7.Google Scholar
  4. 4.
    Jolicoeur LM, Jones-Grizzle AJ, Boyer JG. Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm 1992; 49: 1741–7.PubMedGoogle Scholar
  5. 5.
    Johnstone RE, Martinec CL. Costs of anesthesia. Anesth Analg 1993; 76: 840–8.PubMedGoogle Scholar
  6. 6.
    Rockefeller 3D. Anesthesia and health care reform. Anesth Analg 1993; 76: 689.PubMedCrossRefGoogle Scholar
  7. 7.
    White PF, Watcha MF. Are new drugs cost-effective for patients undergoing ambulatory surgery? (Edit.). Anesthesiology 1993; 78: 2–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Booth MG, Marsh B, Bryden FMM, Robertson EN, Baird WLM. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992; 47: 832–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Rathmell JP, Brooker RF, Prielipp RC, Butterworth JF, Gravlee GP. Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost? Anesth Analg 1993; 76: 513–9.PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1993

Authors and Affiliations

  • David R. Bevan
    • 1
  1. 1.Department of Anaesthesia, Faculty of MedicineUniversity of British ColumbiaVancouver

Personalised recommendations